<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In 64 individuals with <z:hpo ids='HP_0000726'>dementia</z:hpo> (26 Alzheimer type, 34 of vascular origin and 4 other types of <z:hpo ids='HP_0000726'>dementia</z:hpo>) <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E genotype was identified </plain></SENT>
<SENT sid="1" pm="."><plain>Frequency of epsilon4 allele was 36.5% in Alzheimer patients and 32.4% in vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> ones </plain></SENT>
<SENT sid="2" pm="."><plain>In a group of 39 nondemented individuals of the same age the epsilon4 frequency was 11.5% </plain></SENT>
<SENT sid="3" pm="."><plain>In <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> patients, carriers of epsilon4, a tendency to higher plasma levels of atherogenic <z:chebi fb="23" ids="18059">lipids</z:chebi> (total cholesterol and <z:chebi fb="1" ids="47774">low-density lipoprotein cholesterol</z:chebi>) as compared with noncarriers was observed </plain></SENT>
<SENT sid="4" pm="."><plain>It is possible that the epsilon4 form may aggravate the course of <z:hpo ids='HP_0000726'>dementia</z:hpo> through a moderate influence on the atherogenic <z:chebi fb="1" ids="6495">lipoprotein</z:chebi> level </plain></SENT>
<SENT sid="5" pm="."><plain>The results showed that both <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> shared the same risk factors which is consistent with current opinion about a link existing between these two types of <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>